注射器の世界市場：2025～2030年の予測

注射器市場は、CAGR 7.62％で2025年の104億9,100万米ドルから2030年には151億4,800万米ドルに成長すると予測されます。

注射器市場は、慢性疾患の蔓延と急速な高齢化の進展に牽引され、大きな成長が見込まれています。注射器の需要増加は、糖尿病のインスリン投与やその他の慢性疾患のドラッグデリバリーなど、定期的な医療介入の必要性と密接に結びついています。さらに、世界の予防接種プログラムの増加とその重要性に対する意識の高まりが、市場の拡大をさらに後押ししています。製造コストの高さやサプライチェーンの複雑さといった課題が成長の妨げになる可能性はあるものの、市場は、特に米国のような疾病の蔓延率が高く、ヘルスケアシステムが先進的な地域における旺盛な需要に支えられています。

主な成長要因

慢性疾患の有病率の上昇

慢性疾患、特に糖尿病、心血管疾患、がんなどの有病率の世界的な増加は、注射器市場の主な促進要因です。糖尿病管理のためのインスリンなど、頻繁な注射の必要性が注射器の需要を大きく押し上げています。心血管疾患、がん、慢性呼吸器疾患などの非感染性疾患（NCD）の罹患率の増加は、治療・管理プロトコルにおける注射器の必要性をさらに高めています。この動向は、ライフスタイル要因や世界のヘルスケアアクセスの増加により、今後も続くと予想されます。

人口の高齢化

高齢者は注射による治療を必要とする慢性疾患にかかりやすいため、世界の高齢者人口の増加が市場成長に大きく寄与しています。世界的に高齢者人口が増加していることから、薬剤投与や疾病管理用の注射器の需要は増加すると予想され、特に糖尿病や関節リウマチなど、定期的な注射が必要となる疾患が多くあります。

予防接種プログラムの増加

疾病予防における予防接種の役割に対する世界的な意識の高まりは、予防接種プログラムの拡大につながり、注射器需要を牽引しています。政府や医療機関の支援によるこうしたプログラムは、安全で効率的な注射器ソリューションの必要性を強調しており、感染症や慢性疾患からの保護を求める人々の増加に伴い、市場の成長をさらに後押ししています。

目次

第1章 エグゼクティブサマリー

第2章 市場スナップショット

• 市場概要
• 市場の定義
• 調査範囲
• 市場セグメンテーション

第3章 ビジネス情勢

• 市場促進要因
• 市場抑制要因
• 市場機会
• ポーターのファイブフォース分析
• 業界バリューチェーン分析
• ポリシーと規制
• 戦略的提言

第4章 技術展望

第5章 注射器の世界市場：タイプ別

• イントロダクション
• インスリン注射器
• 使い捨て注射器
  • 従来型注射器
    • 偏心チップ注射器
    • カテーテルチップ注射器
    • ルアーロック注射器
  • セーフティ注射器
  • プレフィルド注射器
• その他

第6章 注射器の世界市場：素材別

• イントロダクション
• ガラス
• プラスチック
• ステンレス

第7章 注射器の世界市場：注射器サイズ別

• イントロダクション
• 少量用注射器
• 大容量注射器

第8章 注射器の世界市場：地域別

• イントロダクション
• 北米
  • 米国
  • カナダ
  • メキシコ
• 南米
  • ブラジル
  • アルゼンチン
  • その他
• 欧州
  • ドイツ
  • フランス
  • 英国
  • その他
• 中東・アフリカ
  • サウジアラビア
  • アラブ首長国連邦
  • その他
• アジア太平洋地域
  • 中国
  • インド
  • 日本
  • 韓国
  • 台湾
  • タイ
  • インドネシア
  • その他

第9章 競合環境と分析

• 主要企業と戦略分析
• 市場シェア分析
• 合併、買収、合意およびコラボレーション
• 競合ダッシュボード

第10章 企業プロファイル

• Becton, Dickinson and Company
• B. Braun Melsungen
• Terumo
• Teleflex
• Nipro
• ICU Medical
• Cardinal Health
• HMD Healthcare
• Hamilton Company
• Advancecare Pharma USA
• Baxter International

第11章 付録

• 通貨
• 前提条件
• 基準年と予測年のタイムライン
• 利害関係者にとっての主なメリット
• 調査手法
• 略語

The global syringe market is expected to grow from USD 10.491 billion in 2025 to USD 15.148 billion in 2030, at a CAGR of 7.62%.

The global syringe market is poised for significant growth, driven by the increasing prevalence of chronic diseases and a rapidly aging population. The rising demand for syringes is closely tied to the need for regular medical interventions, such as insulin administration for diabetes and drug delivery for other chronic conditions. Additionally, growing global immunization programs and heightened awareness of their importance further propel market expansion. While challenges such as high production costs and supply chain complexities may hinder growth, the market is supported by robust demand, particularly in regions with high disease prevalence and advanced healthcare systems like the United States.

Key Growth Drivers

Rising Prevalence of Chronic Diseases

The global increase in chronic diseases, particularly diabetes, cardiovascular conditions, and cancer, is a major driver of the syringe market. The need for frequent injections, such as insulin for diabetes management, significantly boosts syringe demand. The growing incidence of non-communicable diseases (NCDs), including cardiovascular illnesses, cancers, and chronic respiratory conditions, further fuels the need for syringes in treatment and management protocols. This trend is expected to continue, driven by lifestyle factors and increasing healthcare access worldwide.

Aging Population

The global rise in the geriatric population significantly contributes to market growth, as elderly individuals are more prone to chronic conditions requiring injectable treatments. With aging populations increasing worldwide, the demand for syringes for drug administration and disease management is expected to rise, particularly for conditions like diabetes and rheumatoid arthritis, which often necessitate regular injections.

Growing Immunization Programs

Increased global awareness of immunization's role in preventing diseases has led to expanded vaccination programs, driving syringe demand. These programs, supported by governments and health organizations, emphasize the need for safe and efficient syringe solutions, further bolstering market growth as populations seek protection against infectious and chronic diseases.

Market Segmentation

By Geography

The syringe market is segmented into North America, South America, Europe, the Middle East and Africa, and Asia-Pacific. The United States is a key market, driven by the high prevalence of chronic diseases like diabetes and cancer, which require frequent syringe use for treatments such as insulin injections and chemotherapy. The country's advanced healthcare infrastructure and focus on innovation further support market growth. Asia-Pacific is expected to witness rapid expansion due to increasing healthcare investments and a growing patient pool in countries like India and China.

Competitive Landscape

Key players, such as Terumo Pharmaceutical Solutions and Nephron Pharmaceuticals Corporation, are driving innovation in the syringe market. These companies focus on developing advanced syringe solutions, such as polymer and cyclic olefin copolymer (COC) syringes, tailored for high-viscosity biotech drugs and improved durability, meeting the evolving needs of the healthcare industry.

The global syringe market is set for robust growth, propelled by the rising prevalence of chronic diseases, an aging population, and expanding immunization programs. The United States leads due to its high disease burden and advanced healthcare systems, while Asia-Pacific shows strong growth potential. Despite challenges like production costs, innovations in syringe design and materials by key players ensure the market's positive trajectory, addressing critical needs in chronic disease management and vaccination efforts.

Key Benefits of this Report:

• Insightful Analysis: Gain detailed market insights covering major as well as emerging geographical regions, focusing on customer segments, government policies and socio-economic factors, consumer preferences, industry verticals, and other sub-segments.
• Competitive Landscape: Understand the strategic maneuvers employed by key players globally to understand possible market penetration with the correct strategy.
• Market Drivers & Future Trends: Explore the dynamic factors and pivotal market trends and how they will shape future market developments.
• Actionable Recommendations: Utilize the insights to exercise strategic decisions to uncover new business streams and revenues in a dynamic environment.
• Caters to a Wide Audience: Beneficial and cost-effective for startups, research institutions, consultants, SMEs, and large enterprises.

What do businesses use our reports for?

Industry and Market Insights, Opportunity Assessment, Product Demand Forecasting, Market Entry Strategy, Geographical Expansion, Capital Investment Decisions, Regulatory Framework & Implications, New Product Development, Competitive Intelligence

Report Coverage:

• Historical data from 2020 to 2024 & forecast data from 2025 to 2030
• Growth Opportunities, Challenges, Supply Chain Outlook, Regulatory Framework, and Trend Analysis
• Competitive Positioning, Strategies, and Market Share Analysis
• Revenue Growth and Forecast Assessment of segments and regions including countries
• Company Profiling (Strategies, Products, Financial Information, and Key Developments among others.

Segmentation:

By Type

• Insulin Syringe
• Disposable Syringes
• Conventional Syringe
• Eccentric Tip Syringe
• Catheter Tip Syringe
• Luer Lock Syringe
• Safety Syringes
• Prefilled Syringes
• Others

By Material

• Glass
• Plastic
• Stainless Steel

By Syringe Size

• Smaller Volume Syringe
• Larger Volume Syringe

By Geography

• North America
• United States
• Canada
• Mexico
• South America
• Brazil
• Argentina
• Others
• Europe
• Germany
• France
• United Kingdom
• Others
• Middle East and Africa
• Saudi Arabia
• UAE
• Others
• Asia Pacific
• China
• India
• Japan
• South Korea
• Taiwan
• Thailand
• Indonesia
• Others

TABLE OF CONTENTS

1. EXECUTIVE SUMMARY

2. MARKET SNAPSHOT

• 2.1. Market Overview
• 2.2. Market Definition
• 2.3. Scope of the Study
• 2.4. Market Segmentation

3. BUSINESS LANDSCAPE

• 3.1. Market Drivers
• 3.2. Market Restraints
• 3.3. Market Opportunities
• 3.4. Porter's Five Forces Analysis
• 3.5. Industry Value Chain Analysis
• 3.6. Policies and Regulations
• 3.7. Strategic Recommendations

4. TECHNOLOGICAL OUTLOOK

5. GLOBAL SYRINGE MARKET BY TYPE

• 5.1. Introduction
• 5.2. Insulin Syringe
• 5.3. Disposable Syringes
  • 5.3.1. Conventional Syringe
    • 5.3.1.1. Eccentric Tip Syringe
    • 5.3.1.2. Catheter Tip Syringe
    • 5.3.1.3. Luer Lock Syringe
  • 5.3.2. Safety Syringes
  • 5.3.3. Prefilled Syringes
• 5.4. Others

6. GLOBAL SYRINGE MARKET BY MATERIAL

• 6.1. Introduction
• 6.2. Glass
• 6.3. Plastic
• 6.4. Stainless Steel

7. GLOBAL SYRINGE MARKET BY SYRINGE SIZE

• 7.1. Introduction
• 7.2. Smaller Volume Syringe
• 7.3. Larger Volume Syringe

8. GLOBAL SYRINGE MARKET BY GEOGRAPHY

• 8.1. Introduction
• 8.2. North America
  • 8.2.1. United States
  • 8.2.2. Canada
  • 8.2.3. Mexico
• 8.3. South America
  • 8.3.1. Brazil
  • 8.3.2. Argentina
  • 8.3.3. Others
• 8.4. Europe
  • 8.4.1. Germany
  • 8.4.2. France
  • 8.4.3. United Kingdom
  • 8.4.4. Others
• 8.5. Middle East & Africa
  • 8.5.1. Saudi Arabia
  • 8.5.2. UAE
  • 8.5.3. Others
• 8.6. Asia Pacific
  • 8.6.1. China
  • 8.6.2. India
  • 8.6.3. Japan
  • 8.6.4. South Korea
  • 8.6.5. Taiwan
  • 8.6.6. Thailand
  • 8.6.7. Indonesia
  • 8.6.8. Others

9. COMPETITIVE ENVIRONMENT AND ANALYSIS

• 9.1. Major Players and Strategy Analysis
• 9.2. Market Share Analysis
• 9.3. Mergers, Acquisitions, Agreements, and Collaborations
• 9.4. Competitive Dashboard

10. COMPANY PROFILES

• 10.1. Becton, Dickinson and Company
• 10.2. B. Braun Melsungen
• 10.3. Terumo
• 10.4. Teleflex
• 10.5. Nipro
• 10.6. ICU Medical
• 10.7. Cardinal Health
• 10.8. HMD Healthcare
• 10.9. Hamilton Company
• 10.10. Advancecare Pharma USA
• 10.11. Baxter International

11. APPENDIX

• 11.1. Currency
• 11.2. Assumptions
• 11.3. Base and Forecast Years Timeline
• 11.4. Key Benefits for the Stakeholders
• 11.5. Research Methodology
• 11.6. Abbreviations